Synthesis and Antitumor Activity of 5-Bromo-7-azaindolin-2-one Derivatives Containing a 2,4-Dimethyl-1H-pyrrole-3-carboxamide Moiety

We report herein the design and synthesis of a series of novel 5-bromo-7-azaindolin-2-one derivatives containing a 2,4-dimethyl-1H-pyrrole-3-carboxamide moiety. These newly synthesized derivatives were evaluated for in vitro activity against selected cancer cell lines by MTT assay. Results revealed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jun, Shen, Weiyi, Li, Xiaoning, Chai, Yun, Li, Senjun, Lv, Kai, Guo, Huiyuan, Liu, Mingliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274105/
https://www.ncbi.nlm.nih.gov/pubmed/27929442
http://dx.doi.org/10.3390/molecules21121674
Descripción
Sumario:We report herein the design and synthesis of a series of novel 5-bromo-7-azaindolin-2-one derivatives containing a 2,4-dimethyl-1H-pyrrole-3-carboxamide moiety. These newly synthesized derivatives were evaluated for in vitro activity against selected cancer cell lines by MTT assay. Results revealed that some compounds exhibit broad-spectrum antitumor potency, and the most active compound 23p (IC(50): 2.357–3.012 μM) was found more potent than Sunitinib (IC(50): 31.594–49.036 μM) against HepG2, A549 and Skov-3, respectively.

Ejemplares similares